(Q82577779)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

9

Alice S Whittemore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

John K Chan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Michael R Manuel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Michael K Cheung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Kathryn Osann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Amreen Husain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Nelson N Teng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Anjali Rao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Robert W Carlson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

17 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

508-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

Association between uterine serous carcinoma and breast cancer

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Tamoxifen therapy for breast cancer and endometrial cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Tamoxifen treatment and gynecologic side effects: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Risk of endometrial cancer after tamoxifen treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Extracolonic cancer in hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.014

10.1016/J.YGYNO.2006.01.014

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16483640%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference